UNDERSTANDING THE ROLES OF EPHRIN A5 IN GLIOBLASTOMA AND ITS POTENTIAL AS A THERAPEUTIC TARGET

被引：1
|
作者：
Skarne, N. [1 ,2 ]
D'Souza, R. [1 ,2 ]
Harris, L. [1 ,2 ]
Baumgartner, U. [2 ]
Offenhauser, C. [1 ]
Akgul, S. [1 ]
Beckett, K. [1 ]
Boyd, A. [1 ]
Day, B. [1 ,2 ]
机构：
[1] QIMR Berghofer Med Res Inst, Brisbane, Qld, Australia
[2] Univ Queensland, Brisbane, Qld, Australia
来源：
NEURO-ONCOLOGY | 2023年 / 25卷
关键词：
D O I：
10.1093/neuonc/noad137.097
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P02.12.B
引用
收藏
页码：32 / 32
页数：1
相关论文
共 50 条
  • [41] Thrombospondin-1 as a Potential Therapeutic Target: Multiple Roles in Cancers
    Wang, Pengfei
    Zeng, Zheng
    Lin, Caiji
    Wang, Jiali
    Xu, Wenwen
    Ma, Wenqing
    Xiang, Qian
    Liu, Huidi
    Liu, Shu-Lin
    CURRENT PHARMACEUTICAL DESIGN, 2020, 26 (18) : 2116 - 2136
  • [42] Annexin A5 in treated hypertensive patients and its association with target organ damage
    Maloberti, Alessandro
    Meani, Paolo
    Vallerio, Paola
    Varrenti, Marisa
    Casadei, Francesca
    Musca, Francesco
    Facchetti, Rita
    Di Blasio, Anna M.
    Ravassa, Susanna
    Mancia, Giuseppe
    Giannattasio, Cristina
    JOURNAL OF HYPERTENSION, 2017, 35 (01) : 154 - 161
  • [43] Osteopontin mediates glioblastoma-associated macrophage infiltration and is a potential therapeutic target
    Wei, Jun
    Marisetty, Anantha
    Schrand, Brett
    Gabrusiewicz, Konrad
    Hashimoto, Yuuri
    Ott, Martina
    Grami, Zacharia
    Kong, Ling-Yuan
    Ling, Xiaoyang
    Caruso, Hillary
    Zhou, Shouhao
    Wang, Y. Alan
    Fuller, Gregory N.
    Huse, Jason
    Gilboa, Eli
    Kang, Nannan
    Huang, Xingxu
    Verhaak, Roel
    Li, Shulin
    Heimberger, Amy B.
    JOURNAL OF CLINICAL INVESTIGATION, 2019, 129 (01): : 137 - 149
  • [44] Understanding necroptosis and its therapeutic target for intervertebral disc degeneration
    Wang, Zheng
    Hu, Xinli
    Wang, Wei
    Li, Yongjin
    Cui, Peng
    Wang, Peng
    Kong, Chao
    Chen, Xiaolong
    Lu, Shibao
    INTERNATIONAL IMMUNOPHARMACOLOGY, 2023, 121
  • [45] DEPDC5 as a potential therapeutic target for epilepsy
    Myers, Kenneth A.
    Scheffer, Ingrid E.
    EXPERT OPINION ON THERAPEUTIC TARGETS, 2017, 21 (06) : 591 - 600
  • [46] 5-hydroxymethylcytosine: a potential therapeutic target in cancer
    Rodger, Euan J.
    Chatterjee, Aniruddha
    Morison, Ian M.
    EPIGENOMICS, 2014, 6 (05) : 503 - 514
  • [47] Fibulin-5 as a potential therapeutic target in COPD
    Brandsma, Corry-Anke
    van den Berge, Maarten
    Postma, Dirkje
    Timens, Wim
    EXPERT OPINION ON THERAPEUTIC TARGETS, 2016, 20 (09) : 1031 - 1033
  • [48] CCR5 is a potential therapeutic target for cancer
    Hemmatazad, Hossein
    Berger, Martin D.
    EXPERT OPINION ON THERAPEUTIC TARGETS, 2021, 25 (04) : 311 - 327
  • [49] Zinc dysregulation in cancers and its potential as a therapeutic target
    Jie Wang
    Huanhuan Zhao
    Zhelong Xu
    Xinxin Cheng
    Cancer Biology & Medicine , 2020, (03) : 612 - 625
  • [50] Zinc dysregulation in cancers and its potential as a therapeutic target
    Jie Wang
    Huanhuan Zhao
    Zhelong Xu
    Xinxin Cheng
    Cancer Biology & Medicine, 2020, 17 (03) : 612 - 625
12345